Assessment of safety in hepatic resection for hepatocellular carcinoma focusing on indirect hyperbilirubinemia

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 3, 2013, Pages 370-374

  Masuda, Toshiro ^a   Beppu, Toru ^a   Nakagawa, Shigeki ^a   Okabe, Hirohisa ^a   Chikamoto, Akira ^a   Miyata, Tatsunori ^a   Mima, Kosuke ^a   Otao, Ryu ^a   Hayashi, Hiromitsu ^a   Doi, Koichi ^a   Ishiko, Takatoshi ^a   Takamori, Hiroshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bilirubin; Hepatectomy; Hepatic resection; Hepatocellular carcinoma

Indexed keywords

ALBUMIN; BILIRUBIN; BILIRUBIN GLUCURONIDE;

AGED; ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; ASCITES; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; INDOCYANINE GREEN CLEARANCE TEST; LIVER CELL CARCINOMA; LIVER MONOSEGMENTECTOMY; LIVER RESECTION; LIVER TRISEGMENTECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PROTHROMBIN TIME; SCINTIGRAPHY; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; TREATMENT INDICATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMORRHAGE; HEPATECTOMY; HUMANS; HYPERBILIRUBINEMIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 84879684686     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0540-8     Document Type: Article

References (20)

1. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176-81.
2. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589-94.
3. Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 2010;24:555-71.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
5. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796-802.
6. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69:299-304.
7. Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed (99m)Tc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol. 2011;46:938-43.
8. Yoshida H, Katayose Y, Rikiyama T, Motoi F, Onogawa T, Egawa S, et al. Segmentectomy of the liver. J Hepatobiliary Pancreat Sci. 2012;19:67-71.
9. Osada S, Saji S. The clinical significance of monitoring alkaline phosphatase level to estimate postoperative liver failure after hepatectomy. Hepatogastroenterology. 2004;51:1434-8.
10. Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, et al. Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg. 2004;239:186-93.
11. Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ. K. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery. 1996;120:34-9.
12. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198-206 (discussion 206).
13. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255-9.
14. Rodriguez-Diaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martinez-Tlahuel JL, et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Clin Oncol (R Coll Radiol). 2007;19:197-203.
15. Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med. 1997;24:130-7.
16. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512-9.
17. Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti J. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl. 2003;9:S18-25.
18. Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM. Protection of the liver during hepatic surgery. J Gastrointest Surg. 2004;8:313-27.
19. Strassburg CP. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev. 2010;42:168-81.
20. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-8 (discussion 8-9).